FDA Inspection
The American National Red CrossThe American National Red Cross – FDA Inspection, May 6, 2026
Record Details
This FDA Inspection record concerns The American National Red Cross, with an inspection on May 6, 2026, issued by the New England District Office, covering biologics.
View Company Profile
ID · d716f248-c80f-4ab1-9562-5ac9ae5fc2be
Inspection Facts
- Inspection number
- 1315850
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.160(b)Required records
- 21 CFR 606.65(e)Following manufacturer's instructions
- 21 CFR 640.25(a)Storage temps./agitation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The American National Red Cross
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for The American National Red Cross
- FDA Inspection 1179574 - 2022-09-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.